Access needle indicator system for locating and accessing subcutaneous medical devices - Patents.com

The access device with sensor-activated alerts improves alignment accuracy for smaller subcutaneous medical ports, reducing mis-sticks and enhancing patient comfort by using capacitive or acoustic detection methods.

JP7581516B2Active Publication Date: 2024-11-12BARD PERIPHERAL VASCULAR INC
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
JP2023531040
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2020-11-24
Publication Date
2024-11-12
Estimated Expiration
2040-11-24

AI Technical Summary

Technical Problem

Existing subcutaneous medical ports, particularly smaller and thinner ones, are difficult to locate accurately due to their reduced size, leading to increased risks of mis-sticking during needle alignment, which can cause patient discomfort and affect wound healing.

Method used

An access device equipped with a needle hub and an indicator system, including capacitive, inductive, or acoustic sensors, to detect changes in dielectric or reflective properties of the port, providing visual, audible, or tactile alerts when the needle is correctly aligned with the port reservoir.

Benefits of technology

The system enhances needle alignment accuracy, allowing for the use of smaller ports with reduced scarring and discomfort, while minimizing mis-sticks without requiring additional imaging equipment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007581516000001
    Figure 0007581516000001
  • Figure 0007581516000002
    Figure 0007581516000002
  • Figure 0007581516000003
    Figure 0007581516000003
Patent Text Reader

Abstract

The embodiments disclosed herein relate to an access device configured to access a subcutaneous medical device. The access device may include a needle supported by a needle hub and, in some embodiments, a housing slidably engaged therewith and configured to align with the needle shaft at a predetermined angle. The access device may include an indicator system configured to detect when the needle is properly aligned with a target window of the port. This may allow for smaller, lower profile ports with smaller target windows while reducing mis-sticks. The indicator system may be included within the access device with little or no increase in the overall dimensions of the access device. The indicator system may use a variety of modalities including capacitive, inductive, magnetic, thermal, acoustic, or radio frequency (RF).
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] Subcutaneous medical devices such as "ports" provide a convenient method of repeated vascular access. Ports are implantable within the body and allow for the infusion of medications, parenteral solutions, blood products, or other fluids. Additionally, ports are used for blood sampling. In a typical method, a port is implanted subcutaneously within the body and a catheter is connected in fluid communication with the port. The catheter is routed to the vasculature where it is desired to deliver or remove fluid. To deliver fluid, a caregiver locates the septum of the port by palpating the patient's skin. [Background technology]

[0002] Port access is achieved by percutaneously inserting a needle, typically a non-coring needle, through the port's septum into the port's reservoir chamber. A fluid containing a drug or some other beneficial agent can then be administered by bolus injection or continuous infusion into the port's chamber. The fluid then flows through the chamber, into the catheter, and finally to the remote site where the fluid is desired.

[0003] Ports, especially port septa, need to be of a certain size to be successfully palpated. However, these relatively large ports can affect wound healing and cause scarring due to skin stretching. Furthermore, port palpation and needle alignment require experience and training, as any slight movement between port palpation and needle alignment can lead to mis-sticks and patient discomfort. Smaller or thinner ports provide improved wound healing, less scarring, and improved aesthetic appearance, improving the overall quality of life for patients. However, these smaller, thinner ports, especially port septa, are more difficult to locate by palpation, increasing the risk of mis-sticks. Summary of the Invention [Problem to be solved by the invention]

[0004] Disclosed herein is an access device, and associated methods, configured to indicate when a needle is properly aligned with a port, allowing for improved needle alignment accuracy and allowing for smaller, thinner ports. [Means for solving the problem]

[0005] Disclosed herein is an access assembly configured to detect and access a subcutaneous medical device, the access device including a needle supported by a needle hub and an indicator system including a capacitance sensor configured to detect a change in dielectric constant between the subcutaneous medical device and surrounding tissue, and an LED light configured to indicate when the needle is aligned with the subcutaneous medical device.

[0006] In some embodiments, the access assembly further includes a housing supporting and slidably engaged with the needle hub, the needle hub configured to transition between a retracted position and an extended position, the housing defining a bottom surface configured to engage a skin surface, and the sensor disposed on the bottom surface. The LED light is disposed on one of the housing or the needle hub. The subcutaneous medical device is a port including a port body and a septum that cooperate to define a reservoir, and the needle is configured to penetrate the septum to access the reservoir below when the needle is aligned with the subcutaneous medical device. The subcutaneous medical device includes a disk of material having a high dielectric constant difference with the surrounding tissue. The disk of material includes one of platinum, silver, tungsten, gold, cobalt, titanium, silica, or zirconia. The disk is disposed below the reservoir and defines a diameter that extends to the same diameter as the reservoir. The sensor can detect changes in dielectric constant from 0.15 inches to 3 inches below the skin surface.

[0007] Also disclosed is a vascular access system including an access device including a needle supported by a needle hub and including a voltmeter sensor and indicator, and a subcutaneous port device including a port body defining a reservoir and a needle septum disposed thereon, the port body including an induction coil configured to induce a current in the voltmeter sensor to activate the indicator to provide an alert.

[0008] In some embodiments, the induction coil may induce a current along an axis extending perpendicular to the skin surface within a range of 0.15 inches to 3 inches. The alert is one of a visual alert, an audible alert, or a tactile alert. The indicator is an LED bulb that is illuminated by a current from a voltmeter induced by the induction coil. In some embodiments, the vascular access system further includes an integrated circuit or "555" timer configured to receive a first voltage from the voltmeter and provide a first output to activate the indicator, and to receive a second voltage from the voltmeter and provide a second output to activate the indicator.

[0009] Also disclosed is a method of accessing a subcutaneous port, the method including engaging a bottom surface of a housing with a skin surface, the housing slidably engaged with a needle hub supporting a needle, the housing aligning an axis of the needle at a predetermined angle relative to the skin surface, detecting a first dielectric constant of tissue disposed below the bottom surface of the housing, sliding the housing parallel to the skin surface, detecting a second dielectric constant different from the first dielectric constant, activating an indicator to provide an alert, and sliding the needle hub relative to the housing to penetrate the skin surface with the needle and access the subcutaneous port.

[0010] In some embodiments, the alert includes one of a visual alert, an audible alert, or a tactile alert. In some embodiments, activating the indicator to provide the alert includes illuminating an LED bulb to indicate that the needle shaft is aligned with the reservoir of the subcutaneous port. The bottom surface of the housing includes a capacitance sensor configured to detect a dielectric constant of tissue disposed below the bottom surface. The subcutaneous port includes a disk of material configured to provide a second dielectric constant. The disk includes one of platinum, silver, tungsten, gold, cobalt, titanium, silica, or zirconia. In some embodiments, the method further includes detecting one of the first dielectric constant or the second dielectric constant to a depth of 0.15 inches to 3 inches below the skin surface. The predetermined angle is 90 degrees or less relative to the skin surface.

[0011] Also disclosed is a method of detecting and accessing a subcutaneous medical device, the method including providing an access device having a needle extending along an axis and supported by a needle hub and an indicator system including a voltmeter sensor and an indicator, aligning the axis of the needle with the skin surface at a predetermined angle, sliding the access device parallel to the skin surface, inducing a current in the voltmeter sensor to activate the indicator, and penetrating the skin surface with the needle to access the subcutaneous medical device.

[0012] In some embodiments, the method further includes a housing including a bottom surface slidably engaged with the needle hub and configured to engage a skin surface to align the needle axis at a predetermined angle. The voltmeter sensor is disposed on one of the needle hub or the bottom surface of the housing. The predetermined angle is 90° or less with respect to the skin surface. The subcutaneous medical device is a port in which an induction coil configured to induce a current in the voltmeter sensor is disposed. In some embodiments, the method further includes receiving a first voltage from the voltmeter sensor and providing a first output to activate the indicator, and receiving a second voltage from the voltmeter sensor and providing a second output to activate the indicator. The first output activates the indicator at a first speed and the second output activates the indicator at a second speed different from the first speed.

[0013] Also disclosed is an access system configured to detect alignment with a subcutaneous medical device, the access system including a needle supported by a needle hub, an acoustic transducer sensor configured to emit an acoustic signal and detect a first reflected signal, and an indicator system having an LED light disposed in the needle hub configured to indicate when a shaft of the needle is aligned with the subcutaneous medical device.

[0014] In some embodiments, the access system further includes a housing supporting and slidably engaged with the needle hub, the needle hub configured to transition between a retracted position and an extended position, the housing defining a bottom surface configured to engage a skin surface, and the acoustic transducer sensor disposed on the bottom surface. The subcutaneous medical device is a port including a port body and a septum that cooperate to define a reservoir, and the needle is configured to pierce the septum to access the reservoir below when the needle is aligned with the subcutaneous medical device. In some embodiments, the acoustic signal strikes the subcutaneous medical device to provide a second reflected signal different from the first reflected signal, and the second reflected signal triggers the LED light to illuminate.

[0015] In some embodiments, the first reflected signal may be relatively weak or absent relative to the second reflected signal. In some embodiments, the first reflected signal indicates a first distance and the second reflected signal indicates a second distance different from the first distance, the second distance being within a predetermined distance range to indicate the presence of the subcutaneous medical device. The subcutaneous medical device includes a disk of material that increases the difference between the first reflected signal and the second reflected signal. The disk of material includes one of platinum, silver, tungsten, gold, cobalt, titanium, silica, or zirconia. The disk is disposed below the reservoir and defines a diameter that extends to the same diameter as the reservoir.

[0016] These and other features of the concepts presented herein will become more apparent to those of ordinary skill in the art in view of the following description and accompanying drawings, which disclose in more detail certain embodiments of such concepts.

[0017] A more detailed description of the present disclosure will now be given with reference to certain embodiments illustrated in the accompanying drawings. It will be understood that these drawings represent only typical embodiments of the present invention and therefore should not be considered limiting of its scope. Exemplary embodiments of the present invention will be described and explained with additional features and details using the following accompanying drawings. [Brief description of the drawings]

[0018] [Figure 1] 1 illustrates an exemplary environment for use of an access system, according to one embodiment of the present invention. [Figure 2A] 1 shows a side view of an exemplary implantable medical device, in accordance with an embodiment of the present invention. [Figure 2B] 1 illustrates a side view of an access assembly in accordance with an embodiment of the present invention. [Figure 3A-3C] 1 shows a side view of an access system according to an embodiment of the present invention. [Figure 4A-4C] 1 shows a side view of an access system according to an embodiment of the present invention. [Figure 5A-5C]1 illustrates a top view of an access system according to an embodiment of the present invention. [Figure 6A-6C] 1 shows a side view of an access system according to an embodiment of the present invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0019] Reference is now made to the figures, in which like structures are given like reference numerals. It is understood that the drawings are illustrative and schematic representations of exemplary embodiments of the present invention, and are not limiting and are not necessarily drawn to scale. Before some specific embodiments are disclosed in more detail, it should be understood that the specific embodiments disclosed herein do not limit the scope of the concepts provided herein. It should also be understood that the specific embodiments disclosed herein may have features that can be easily separated from the specific embodiment and can be combined or substituted in any way with any of the other several embodiments disclosed herein.

[0020] With respect to the terms used herein, it should also be understood that the terms are intended to describe certain particular embodiments, and that the terms do not limit the scope of the concepts provided herein. Ordinal numbers (e.g., first, second, third, etc.) are generally used to distinguish or identify different features or steps within a group of features or steps, and do not provide a sequential or numerical limitation. For example, first, second, and third features or steps need not appear in that order, nor are particular embodiments that include such features or steps limited to those three features or steps. Labels such as "left," "right," "front," "rear," "top," "bottom," "front," "rear," "clockwise," "counterclockwise," "top," "bottom," and other similar terms such as "upper," "lower," "rear," "front," "vertical," "parallel," "base," "distal," and the like, and similar terms are used for convenience and are not intended to imply, for example, a particular fixed position, orientation, direction, etc. Instead, such labels are used to reflect, for example, relative positions, orientations, directions, etc. The singular forms "a," "an," and "the" include plural references unless the context clearly dictates otherwise. Additionally, the words "including," "having," and "having" have the same meaning as the word "comprising" when used in this specification, including the claims.

[0021] For example, references to the "proximal," "proximal portion," or "base end" of a needle disclosed herein include the portion of the needle that is intended to be located near the clinician when the needle is used on a patient. Similarly, for example, the "proximal length" of a needle includes the length of the needle that is intended to be located near the clinician when the needle is used on a patient. For example, the "proximal end" of a needle includes the end of the needle that is intended to be located near the clinician when the needle is used on a patient. The proximal, proximal, or proximal length of a needle may include the proximal end of the needle. However, the proximal, proximal, or proximal length of a needle need not include the proximal end of the needle. That is, unless the context suggests otherwise, the proximal, proximal, or proximal length of a needle is not the distal, or distal length of the needle.

[0022] For example, references to the "distal," "distal portion," or "tip" of a needle disclosed herein include the portion of the needle intended to be located near or within the patient when the needle is used on a patient. Similarly, for example, the "distal length" of a needle includes the length of the needle intended to be located near or within the patient when the needle is used on a patient. For example, the "distal end" of a needle includes the end of the needle intended to be located near or within the patient when the needle is used on a patient. The distal, tip, or distal length of a needle may include the distal end of the needle. However, the distal, tip, or distal length of a needle need not include the distal end of the needle. That is, unless the context suggests otherwise, the distal, tip, or distal length of a needle is not the terminal, or end, length of the needle.

[0023] As used herein, an "integrated circuit" ("IC") may include one or more of analog, digital or hybrid circuit components, monolithic integrated circuits, silicon chips, semiconductor chips, "chips," "microchips," "555" timers, processors, non-transitory memory, and the like.

[0024] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art. Embodiments of the present invention generally relate to an access system configured to indicate proper alignment with an implanted medical device placed within a patient's body to reduce mis-sticks. One example of such a medical device includes an implantable vascular access port, whereby a variety of other implantable devices may benefit from use of the system. Ports, particularly low-profile port septa, can be difficult to find once the port is implanted under the skin, and proper alignment of the access needle is even more difficult. Thus, there is a need for an access device to confirm proper alignment and reduce mis-sticks.

[0025] FIG. 1 illustrates an exemplary environment of use of an access system 100 according to one embodiment. The access system 100 includes an access device 150 and a subcutaneous medical device, such as a vascular access port ("port") 200. As used herein, the port 200 is used as an exemplary medical device, but it will be appreciated that embodiments of the system 100 may also include other implantable medical devices, such as catheters, stents, pumps, combinations thereof, and the like. Additionally, the port 200 is shown throughout the drawings with certain features, such as septum ridges, suture holes, and the like, which are optional. Additionally, the port 200 is shown with a shape, which is also optional. It should be appreciated that the access system described herein is capable of any type of vascular access port or other implanted medical device. The port 200 is implanted subcutaneously in the patient 10 with the catheter 300 fluidly connecting the port 200 with the vasculature 20 of the patient 10.

[0026] An access device 150 can percutaneously access the port 200 to deliver medications or other fluids to the port 200 and via a catheter 300 to the patient's vasculature 20. As used herein, an access device 150 can include any infusion set, expansion set, or needle device that can be used to fluidly access the implanted port 200 for delivery of medications or other fluids.

[0027] 2A-2B show further details of the access system 100 for aligning an implanted medical device 200 (e.g., a port) with an access device 150, according to one embodiment. As shown in FIG. 2A, the port 200 includes a body 212 and a needle-penetrable septum 214 that cooperates with the body 212 to define a fluid reservoir 216. Optionally, the port body 212 may include suture holes 208. An indwelling catheter 300 is fluidly connected to an outlet 218 of the reservoir 216 of the port 200 to allow delivery of medication or other fluids to the vasculature 20 of the patient 10 via the needle 152 of the access device 150 (via the needle piercing the septum 214) that are delivered percutaneously to the port reservoir 216.

[0028] 2B, the access device 150 may include a needle 152 supported by a needle hub 154. The needle 152 may be a non-coring needle, a Huber needle, a "bendable" needle, or the like, configured to pierce the skin surface 90 and the port septum 214 to access the reservoir 216 of the subcutaneous port 200. The needle 152 may define a lumen 156 that provides fluid communication between a tip opening 158 disposed adjacent a distal tip of the needle 152 and an extension leg 160 extending from the needle hub 154.

[0029] In an embodiment, as shown in FIGS. 6A-6C, the needle 152A may include a “bendable” needle 152A or cannula. The bendable needle 152A may be inserted to access the port 200 as described herein. Once the distal opening 158 is positioned within the reservoir 216, the portion of the needle adjacent the skin surface may be configured to bend so that the proximal portion of the needle positioned outside the body may lie on the skin surface. In an embodiment, a portion of the needle 152A may be heat treated to make it malleable, allowing the needle to bend. This may be contrasted with a portion of the needle 152A that is not heat treated and is substantially rigid or inflexible. In an embodiment, a portion of the needle 152A may include a different material or a different physical structure (e.g., braid, coil, perforations, etc.) to allow that portion of the needle 152A to bend. In some embodiments, the access device 150 may further include a trocar 162, or similar device, disposed within the needle lumen to support the needle during insertion and prevent the bent portion of the needle from buckling prematurely. Once the needle 152A is inserted, the trocar 162 may be removed and the needle may be bent to lie on the skin surface as described herein. Advantageously, the "bent" needle 152A may access ports 200 located at different depths below the skin surface while the remaining portion of the needle 152A may be bent to lie on the skin surface.

[0030] In an embodiment, the access device 150 may further include a housing 170 configured to support and be slidably engaged with one of the needle 152 or the needle hub 154. The housing 170 may define a bottom surface 172 configured to engage a skin surface 90 of a patient. The bottom surface 172 may align an axis (a) of the needle 152 with respect to the skin surface 90. In an embodiment, the bottom surface 172 may align the axis of the needle 152 at a predetermined angle (θ) with respect to the skin surface 90. The predetermined angle (θ) may be less than or equal to 90° with respect to the skin surface 90. Advantageously, the predetermined angle (θ) may align the needle tip opening 158 to access the reservoir.

[0031] 2A, in an embodiment where the predetermined angle (θ) is substantially 90° relative to the skin surface 90, the septum 214 provides the largest possible target window (x) for accessing the reservoir 216, reducing mis-sticks. Additionally, the needle 152 may traverse the septum 214 at a minimum perpendicular distance, increasing the lifespan of the septum 214. However, when the needle 152 is at an angle <90° relative to the skin surface 90, the target window (y) is substantially smaller. As will be appreciated, any inadvertent deviation from the 90° angle by a user without the benefit of the embodiments disclosed herein may dramatically increase the probability of a mis-stick.

[0032] In embodiments where the predetermined angle (θ) is an angle <90° with respect to the skin surface 90, the needle tip opening 158 may be located entirely within the reservoir 216 while the reservoir 216 requires a generally lower vertical height, making the port 200 overall thinner. Further details of such ports may be found in International Publication WO 2020 / 028847, filed August 2, 2019, which is incorporated by reference in its entirety. The embodiments described herein may either maintain the 90° angle, or where the predetermined angle (θ) is intentionally less than 90°, the embodiments may provide the user with greater precision to reduce mis-sticking of the low-profile port.

[0033] In an embodiment, the needle hub 154 may be slidably engaged with the housing 170 along an axis extending parallel to the axis (a) of the needle 152. As such, the needle hub 154 may transition between a retracted position (FIGS. 2B, 3B) and an extended position (FIG. 3C). In the retracted position, the distal tip of the needle 152 may be disposed above the bottom surface 172 of the housing 170, allowing the needle 152 to be disposed within the housing 170. Advantageously, the needle 152 in the retracted position may reduce accidental needle stick injuries. In the extended position, the distal tip of the needle 152 may extend below the bottom surface 172 of the housing 170, allowing the needle 152 to penetrate the skin surface 90 engaged with the bottom surface 172.

[0034] 3A-3C, during use, a clinician may manipulate the access device 150 until the bottom surface 172 of the housing 170 engages the skin surface 90 and the needle 152 is aligned with a target window in the subcutaneously disposed septum 216 below. The clinician then slides the needle hub 154 from a retracted position (FIG. 3B) to an extended position (FIG. 3C) such that the needle 152 penetrates the port septum 216 and the tip opening 158 accesses the reservoir 216.

[0035] As noted herein, locating the port 200 may be done by palpation of the patient's skin surface to facilitate alignment of the needle 152 with the port septum 216. However, this requires the port 200 and / or the port septum 216 to be large enough to be successfully palpated. During placement of such a large port, the skin may be stretched, which may lead to prolonged wound healing, increased scarring, and increased discomfort, which may have adverse effects on the patient.

[0036] In one embodiment, the access device 150 may include an indicator system 180 configured to indicate to the clinician when the needle 150 is aligned with the target window of the port 200. Advantageously, the indicator system 180 may indicate to the clinician when the needle 150 is aligned with the port 200 without any need for palpation of the port 200. Additionally, the indicator system 180 may provide for fairly accurate alignment of the port 200 and the needle 152, allowing for a smaller, thinner port 200, or angled insertion into the port. These smaller ports may provide improved wound healing, less scarring, and less discomfort to the patient.

[0037] Advantageously, indicator system 180 may be included within access device 150, i.e., needle hub 154 and / or housing 170, to conveniently indicate proper alignment with port reservoir 216 at the insertion site. As such, the clinician does not need to divert attention from the insertion site to verify alignment. Furthermore, access device 150 does not require any additional imaging equipment, console, monitor, or computing equipment associated therewith to verify alignment. This may further reduce the cost required for additional equipment and the expertise required to operate such additional equipment.

[0038] In an embodiment, indicator system 180 may include an indicator 182 configured to alert the user when needle 152 is aligned with port 200 via one of a visual, audible, or tactile alert. For example, the access device may include an LED indicator 182 configured to light up or change color when needle 152 is properly aligned. In an embodiment, the LED may project an image or symbol onto skin surface 90. In an embodiment, access device 150 may provide a vibration or an audible alert when needle 152 is properly aligned. In an embodiment, either needle hub 154 or housing 170 may be formed of a transparent or translucent material and may refract light of LED 182 therethrough.

[0039] In an embodiment, indicator system 180 may include one or more sensors 184 disposed within access device 150 and configured to detect the presence of a port 200 disposed thereunder. When the presence of a port 200 is detected, indicator system 180 activates an indicator to alert the clinician that the axis of needle 152 is properly aligned with port reservoir 216. Optionally, indicator system 180 may include a power source configured to power sensor 184, indicator 182, and any associated circuit components.

[0040] As shown in Figures 3A-3C, in some embodiments, the sensor may be disposed within the bottom surface 172 of the housing and configured to contact the skin surface 90. As shown in Figures 4A-4C, in some embodiments, the sensor 184 may be disposed within the needle hub 154. In some embodiments, as shown in Figures 5A-5C, the sensor 184 may be an array of two or more sensors disposed about the axis (a) of the needle 152. In some embodiments, the sensor 184 may define a toroidal shape and be disposed in an annular configuration about the axis (a) of the needle 152.

[0041] 4A-4C show an embodiment of an access device 150 including an indicator system 180 disposed within a needle hub 154. As shown, the access device 150 may be provided without a housing 170. A clinician may guide the access device 150 above the skin surface 90 (FIG. 4A) until a sensor 184 detects that the axis of the needle 152 is properly aligned with the port reservoir 216 (FIG. 4B). The indicator system 180 may so indicate by activating an indicator 182. The clinician may then percutaneously insert the needle to access the port 200 (FIG. 4C). Advantageously, the access device 150 of FIGS. 4A-4C, including the indicator system 180, adds little or no increase in the overall dimensions of the access device 150 relative to the needle and needle hub assembly alone. As such, the clinician may access smaller, thinner ports and maintain attention to the insertion site while reducing the likelihood of mis-sticking without the use of any additional monitors, computing devices, etc.

[0042] 5A-5C show plan views of an embodiment of the access system 100. As shown in FIG. 5A, the access device 150 is not aligned with the target window of the septum 216. The sensor 184 cannot detect the port located thereunder and the indicator 182 is not activated. As shown in FIGS. 5B-5C, by sliding the access device 150 on the skin surface 90 toward the location of the port 200, the sensor 184 can detect when the axis of the needle 152 is sufficiently aligned with the septum 216 to access the reservoir thereunder. The sensor 184 can detect the presence of the port 200 located subcutaneously and alert the clinician when the needle is sufficiently aligned with the port reservoir 216 by activating the indicator 182 (FIG. 5C).

[0043] In an embodiment, indicator system 180 can detect the presence of port 200 by one or more modalities. As described in more detail herein, exemplary modalities can include capacitive, inductive, magnetic, thermal, acoustic, radio frequency (RF), combinations thereof, and the like.

[0044] Capacitive Modality In one embodiment, the indicator system 180 may use a capacitance modality and may include a capacitance sensor plate 184 and associated circuit components configured to detect changes in the dielectric constant of tissue disposed below the bottom surface 172 of the access device 150.

[0045] For example, as shown in FIG. 3A, the capacitance of the skin surface tissue may provide a first permittivity measurement. As shown in FIG. 3B, the capacitance of the port 200 located subcutaneously may provide a second permittivity measurement that is different from the first permittivity measurement. The indicator system 180 may detect the change in capacitance of the tissue located therebelow and indicate that the needle 152 is aligned with the port septum 214 and reservoir 216, for example, by illuminating an LED 182. As shown in FIG. 3C, the clinician slides the needle hub 154 from a retracted position to an extended position to access the port 200. The range of the capacitance modality sensor 184 may be 0.15 inches to 3 inches below the skin surface. Larger or smaller ranges are also contemplated. Advantageously, the capacitance modality of the indicator system 180 may detect the presence of the port 200 without requiring the port 200 to provide any active or return signal. As such, access device 150 may be used with a variety of subcutaneous medical devices without requiring any specific adaptation.

[0046] In an embodiment, the port 200, or a portion thereof, may include a material that provides a different capacitance to the surrounding tissue or a different dielectric constant to the surrounding material. For example, the port body 212, or a portion thereof (e.g., the disk 220) may include a material such as platinum, silver, tungsten, gold, cobalt, titanium, silica, zirconia material, or similar material that provides an increased capacitance or dielectric constant difference to the surrounding material. In an embodiment, the disk 220 of material may be denser relative to one or more materials forming the port 200 or the surrounding tissue. In an embodiment, the portion of material, e.g., the disk 220, may be positioned below the reservoir 216 or may form the reservoir base and may indicate a target window (e.g., target window (x)) of the reservoir 216 (see FIGS. 5A-5C). In other words, the diameter of the disk 220 may be substantially aligned with the diameter of the reservoir 216. A change in capacitance between the surrounding tissue and the port body 212 , including the disk 220 , may indicate the presence of the port 200 and improve the alignment of the needle 152 with the port 200 .

[0047] Guidance Modality In an embodiment, the indicator system 180 may include an induction coil 222 disposed within the port body 212. The induction coil 222 may induce a current in a voltmeter sensor 184 disposed within the access device 150, which may in turn illuminate the LED indicator 182. The strength of the induction coil 222 may be configured to induce a current within a predetermined range of the port or in a predetermined direction from the port. An exemplary range may be 0.15 inches to 3 inches, although larger or smaller ranges are contemplated. Additionally, the induction coil 222 may be positioned to induce a current along an axis extending perpendicular to the skin surface 90. As such, the induction coil 222 may induce a current in the voltmeter sensor 184 when the access device is positioned directly over the top side of the port reservoir 216 (e.g., FIG. 3B). When the access device 150 is not aligned with the port reservoir, the voltmeter sensor 184 is out of range of the induction coil 222, no current is induced, and the LED indicator 182 is not illuminated.

[0048] Advantageously, the LED 182, voltmeter sensor 184, and associated circuitry provide a compact indicator system 180 as the access device 150 does not require a power source. Instead, power is provided by an inductive coil 222 disposed within the port 200. As such, the inductive indicator system 180 may be contained within the access device 150 with little or no increase in the overall size of a comparable access device 150 that does not include the indicator system 180.

[0049] In an embodiment, the voltmeter sensor 184 may include a coil. An induction coil 222 located in the port 200 may pick up a voltage from a coil located in the voltmeter sensor 184 when the needle 152 is aligned with the port 200. The voltmeter may then detect a voltage drop across the coil located in the voltmeter 184 to confirm that the induction coil 222 is within range, i.e., located below the voltmeter sensor 184, thereby aligning the axis (a) of the needle 152 with the port reservoir 216. The indicator system 180 may then alert the user by illuminating an LED, as described herein.

[0050] In an embodiment, indicator system 180 may include one or more integrated circuits ("ICs") or the like configured to detect a predetermined voltage set point received from sensor 184 and provide a predetermined output to one or more visual, audible, or tactile indicators, such as LED 182. For example, as shown in FIGS. 5A-5C, system 100 may include a circuit component, such as a "555" timer, configured to detect a first voltage input indicative of a first proximity to port 200 and provide a first output of a first blink rate of LED light 182. As access device 150 is moved closer to port 200, thereby becoming more aligned with reservoir 216, subsequent voltage measurements, such as a second voltage measurement or a third voltage measurement, may indicate a progressive improvement in the alignment of needle 152 with port reservoir 216. As such, the IC or “555” timer may provide a second blinking rate of the LED 182 faster than the first rate, and a third blinking rate faster than the second rate, until the needle 152 is aligned with the port reservoir 216.

[0051] In some embodiments, the different voltage readings from the sensor 184 may be provided by an increase in the strength of the signal detected by the sensor 184. In some embodiments, the different voltage readings may be provided by a different number of sensors in the sensor array 184 that detect the presence or absence of an underlying port 200. For example, as shown in FIGS. 5A-5C, two or more sensors of the sensor array 184 may be arranged in a ring shape around the axis of the needle 152. As shown in FIG. 5B, when an edge of the port 200 is located below a first sensor of the sensor array 184, a first voltage reading may be provided indicating that the port is nearby but not properly aligned with the access device 150. As shown in FIG. 5C, when all of the sensors of the sensor array 184 detect the presence of the port 200, a second voltage reading different from the first voltage reading may be provided indicating that the port 200 is properly aligned with the needle 152.

[0052] It will be appreciated that this is exemplary and that the IC or "555" timer may provide other modalities, or other indicators, for indicator system 180, such as a change in color of an LED, an audible signal, such as the rate, pitch, frequency, amplitude of a signal, or the rate, frequency or amplitude of a vibration signal. These and other forms of modalities or indicator signals are contemplated as falling within the scope of the present invention.

[0053] Magnetic Modality In an embodiment, the indicator system 180 may use a magnetic modality. The port 200 may include a portion, such as the disk 200, that includes a ferrous or magnetic material that provides a passive magnetic field strength. The sensor 184 may include a magnetic, or "Hall Effect" sensor configured to detect a difference in magnetic field strength between the surrounding tissue and the port 200, including the disk 220. When the access device 150 is aligned with the port 200, the magnetic field strength may indicate when the port reservoir 216 is aligned directly beneath the needle 152, as described herein. A user may then manipulate the needle hub 154 to access the port reservoir 216.

[0054] Thermal Modality In an embodiment, the indicator system 180 may include a thermal sensor 184 and associated circuitry configured to detect a temperature change in tissue disposed beneath the access device 150 using a thermal modality. As shown in FIG. 3A, the temperature of the skin surface tissue may provide a first temperature. As shown in FIG. 3B, the port 200 disposed subcutaneously may provide a different temperature than the surrounding tissue, for example, in FIG. 3B. The indicator system 180 may detect the temperature change and indicate that the needle 152 is aligned with the port septum 214 and reservoir 216 disposed beneath it, for example, by illuminating an LED 182. As shown in FIG. 3C, the clinician may slide the needle hub 154 from a retracted position to an extended position to access the port 200. The temperature modality sensor 184 may range from 0.15 inches to 3 inches, although larger or smaller ranges are contemplated. Advantageously, the surface contact temperature sensor 184 can provide a precise temperature detection window located beneath the access device 150 to provide precise alignment of the port reservoir 216 and the needle.

[0055] Acoustic Modality In one embodiment, indicator system 180 can use an acoustic modality and can include an acoustic transducer and sensor 184, and associated circuit components, configured to emit an acoustic, e.g., ultrasonic, signal to tissue disposed beneath access device 150. Additionally, acoustic sensor 184 can detect reflected acoustic signals from tissue disposed beneath access device 150.

[0056] As shown in Figure 3A, the transducer sensor 184 can provide an acoustic signal directed to tissue located immediately beneath the access device 150. The skin surface tissue can provide a first reflected acoustic signal. As shown in Figure 3B, when the access device 150 is aligned with the port reservoir 216, the emitted acoustic signal reflects off the subcutaneously located port 200, providing a second reflected acoustic signal that is different from the first reflected acoustic signal.

[0057] In some embodiments, the first reflected signal may be a relatively weak or absent signal compared to the second reflected signal, and as such, the transducer sensor 184 may detect the port 200 due to the presence of the second reflected signal or an increase in the strength of the second reflected signal compared to the first reflected signal.

[0058] In one embodiment, the first reflected signal can detect a first subcutaneous object, such as a bone, at a first distance calculated from the time elapsed between the emitted signal and the reflected signal. The second reflected signal can detect a second subcutaneous object, such as port 200, at a second distance that is less than the first distance or within a predetermined range. As such, if the second reflected signal is within the predetermined range, the presence of port 200 is confirmed. In one embodiment, the predetermined range of the acoustic signal can be between 0.15 inches and 3 inches, although larger or smaller ranges are contemplated.

[0059] The indicator system 180 can detect the reflected acoustic signal and determine the presence of the port 200 located thereunder. As such, the indicator system 180 can alert the user that the needle 152 is aligned with the port septum 214 and reservoir 216 located thereunder, for example, by illuminating the LED 182. As shown in FIG. 3C, the clinician can then slide the needle hub 154 from a retracted position to an extended position to access the port 200. In an embodiment, the acoustic modality of the indicator system 180 can detect the presence of the port 200 without requiring the port 200 to provide any active signal. As such, the acoustic modality access device 150 can be used with a variety of subcutaneous medical devices without requiring any specific adaptation.

[0060] In an embodiment, the port 200, or a portion thereof, may include a material that provides different acoustic reflection properties relative to the surrounding tissue. For example, the port 200 may include a disk 220 of material disposed within the port body 212 below the reservoir 216 as described herein. A change in acoustic reflection properties between the surrounding tissue and the port body 212, including the disk 220, may provide an indication of the presence of the port 200 and alignment with the needle 152. In an embodiment, the disk 220 of material may densify relative to the material or materials forming the port 200 or the surrounding tissue. In an embodiment, the disk 220 may include one of platinum, silver, tungsten, gold, cobalt, titanium, silica, or zirconia. However, other materials with different acoustic properties are contemplated.

[0061] RFID Modality In one embodiment, indicator system 180 may use a radio frequency (RF) modality and may include an RFID emitter and sensor 184, and associated circuit components, configured to emit an RF signal into tissue disposed beneath the access device 150 and to detect reflected RFID signals from tissue disposed beneath the access device 150.

[0062] As shown in FIG. 3A, the RFID emitter and sensor 184 may provide an RF signal directed to tissue located directly below the access device 150. In the absence of any ports 200 and associated RFID tags 220A located thereunder, no reflected signal is provided, indicating that the needle 152 is not aligned with the port reservoir 216. As shown in FIG. 3B, when the access device 150 is aligned with the port reservoir 216, the RFID signal emitted from the sensor 184 reflects off the RFID tag 220A located within the subcutaneously located port 200, providing a difference in the reflected response signal. The transducer sensor 184 of the indicator system 180 may detect the reflected response signal and indicate that the needle 152 is aligned with the port septum 214 and reservoir 216 located thereunder, for example, by illuminating the LED 182. As shown in FIG. 3C, the clinician may then slide the needle hub 154 from the retracted position to the extended position to access the port 200. The distance range of the RFID signal emitted from the RFID emitter and sensor 184 may penetrate surface skin tissue to a depth of 0.15 inches to 3 inches, although larger or smaller ranges are contemplated.

[0063] Advantageously, the RFID reflected signal may provide a specific response signal from the port 200 and reduce the presence of false positives. This may improve the accuracy of detection and alignment of the access device 150 with the port reservoir 216 and reduce mis-sticks. Furthermore, the RFID tag 220A disposed within the port 220 does not require any additional power source to provide the response signal. Instead, the power to provide the response signal is derived from the energy of the emitted RFID signal provided from the RFID emitter sensor 184 of the access device 150.

[0064] The embodiments of the present invention may be embodied in other specific forms without departing from the spirit of the disclosure. The described embodiments are to be considered in all respects merely as illustrative and not restrictive. The scope of the embodiments is therefore indicated by the appended claims, rather than by the foregoing description. All changes that come within the meaning and range of equivalency of the claims are embraced within their scope.

Claims

1. 1. An access assembly configured to detect and access a subcutaneous medical device, comprising: a needle supported by a needle hub; 1. An indicator system comprising: a capacitance sensor configured to detect a change in dielectric constant between the subcutaneous medical device and surrounding tissue; an LED light configured to indicate when the needle is aligned with the subcutaneous medical device; and An access assembly comprising:

2. a housing supporting said needle hub and slidably engaged therewith; the needle hub is configured to transition between a retracted position and an extended position; the housing defines a bottom surface configured to engage a skin surface; The access assembly of claim 1 , wherein the sensor is disposed on the bottom surface.

3. The access assembly of claim 2 , wherein the LED light is disposed on one of the housing or the needle hub.

4. the subcutaneous medical device is a port including a port body and a septum that cooperate to define a reservoir; 4. The access assembly of claim 1, wherein the needle is configured to pierce the septum to access the reservoir therebelow when the needle is aligned with the subcutaneous medical device.

5. The access assembly of claim 1 , wherein the subcutaneous medical device includes a disk of a material that has a high dielectric constant difference with the surrounding tissue.

6. The access assembly of claim 5 , wherein the disk of material comprises one of platinum, silver, tungsten, gold, cobalt, titanium, silica, or zirconia.

7. The access assembly of claim 5 or 6, wherein the disk is positioned below the reservoir and defines a diameter extending coaxially with the reservoir.

8. The access assembly of any one of claims 1 to 7, wherein the sensor is capable of detecting changes in dielectric constant to a depth of 3.81 mm to 76.2 mm below the skin surface.

9. 1. A vascular access system comprising: an access device including a needle supported by a needle hub and including a voltage meter sensor and indicator; 1. A subcutaneous port device comprising a port body defining a reservoir and a needle septum disposed thereover, a subcutaneous port device, the port body including an induction coil configured to induce a current in the voltmeter sensor to activate the indicator to provide an alert when the needle is aligned with the subcutaneous medical device; A vascular access system comprising:

10. 10. The vascular access system of claim 9, wherein the induction coil is capable of inducing a current along an axis extending perpendicular to the skin surface within a range of 3.81 mm to 76.2 mm.

11. 11. The vascular access system of claim 9 or 10, wherein the alert is one of a visual alert, an audible alert, or a tactile alert.

12. 12. The vascular access system of claim 9, wherein the indicator is an LED bulb that is illuminated by current from the voltmeter induced by the induction coil.

13. 13. The vascular access system of any one of claims 9 to 12, further comprising an integrated circuit or "555" timer configured to receive a first voltage from the voltmeter and provide a first output for activating the indicator, and to receive a second voltage from the voltmeter and provide a second output for activating the indicator.

14. 1. An access system configured to detect alignment with a subcutaneous medical device, comprising: a needle supported by a needle hub; 1. An indicator system comprising: an acoustic transducer sensor configured to emit an acoustic signal and detect a first reflected signal; an indicator system comprising: an LED light disposed on the needle hub configured to indicate when the subcutaneous medical device and the needle shaft are aligned; An access system comprising:

15. a housing supporting said needle hub and slidably engaged therewith; the needle hub is configured to transition between a retracted position and an extended position; the housing defines a bottom surface configured to engage a skin surface; The access system of claim 14 , wherein the acoustic transducer sensor is disposed on the bottom surface.

16. the subcutaneous medical device is a port including a port body and a septum that cooperate to define a reservoir; 16. The access system of claim 14 or 15, wherein the needle is configured to pierce the septum to access the reservoir therebelow when the needle is aligned with the subcutaneous medical device.

17. the acoustic signal impinges on the subcutaneous medical device to provide a second reflected signal different from the first reflected signal; 17. The access system of claim 14, wherein the second reflected signal triggers the LED light to turn on.

18. 20. The access system of claim 17, wherein the first reflected signal is relatively weak or absent with respect to the second reflected signal.

19. the first reflected signal indicates a first distance and the second reflected signal indicates a second distance different from the first distance; 20. The access system of claim 17, wherein the second distance is within a predetermined distance range to indicate a presence of the subcutaneous medical device.

20. 20. The access system of any one of claims 17 to 19, wherein the subcutaneous medical device includes a disk of material that increases the difference between the first reflected signal and the second reflected signal.

21. 21. The access system of claim 20, wherein the disk of material comprises one of platinum, silver, tungsten, gold, cobalt, titanium, silica, or zirconia.

22. 22. The access system of claim 20 or 21, wherein the disk is positioned below the reservoir and defines a diameter extending coaxially with the reservoir.

Citation Information

Patent Citations

  • System and method for identifying and locating implanted devices

    JP2013531999A

  • Medical apparatus, extracorporeal unit, transmission sheet, medical instrument, and position detection method

    JP2020182679A

  • Vascular access device and method

    US20200069929A1